Amphotericin B (AmB) has toxic effects and alters neutrophil (polymorphonuclear leukocyte [PMN]) function. A lipid-complexed formulation of AmB (AmB-LC) has been reported (A. S. Janoff, L. T. Boni, M. C. Popescu, S. R. Minchey, P. R. Cuilis, T. D. Madden, T. Taraschi, S. M. Gruner, E. Shyamsunder, M. W. Tate, R. Mendelsohn, and D. Bonner, Proc. Natl. Acad. Sci. USA 85:6122-6126, 1988) to be less toxic than a desoxycholate-suspended preparation of AmB (AmB-des; Fungizone). In this study we compared the effects of AmB-des and AmB-LC on in vitro PMN function. Neither form of AmB stimulated PMN chemiluminescence, but AmB-des (2 ,ug/mI) nearly tripled PMN chemiluminescence in response to f-Met-Leu-Phe (fMLP), a phenomenon known as priming. Because AmB stimulates monocytes to release cytokines which can affect PMN function, we studied the effects of AmB on PMNs in mixed leukocyte cultures. AmB-des (1 to 2 ,ug/ml) increased the chemiluminescence of PMNs plus mixed mononuclear leukocytes (MNLs) to fMLP. The activity was about three times that of PMNs plus MNLs and seven times the activity of PMNs stimulated with fMLP in the absence of MNLs. Cell-free AmB-des (2 ,ug/ml)-stimulated, MNL-conditioned medium primed pure PMNs to a level equal to that of whole MNLs treated with AmB-des. AmB-LC was much less potent. AmB-LC (20 ,ug/ml) increased fMLP-stimulated chemiluminescence to two times that of PMNs plus MNLs without AmB-LC. AmB-des (2 ,ug/ml) (but not AmB-LC [2 ,ug/ml]) increased nitroblue tetrazolium reduction by PMNs in whole blood from 31 to 52% of positive cells. Neither form of AmB increased Mac-1 (the CD11b/CD18 integrin) expression of pure PMNs. AmB-des (0.5 to 2 ,ug/ml) (but not AmB-LC [c40 ,ug/ml]) nearly doubled PMN Mac-1 expression in the presence of MNLs, and cell-free AmB.des (2 ,ug/ml)-stimulated, MNL-conditioned medium stimulated PMN Mac-i to l25% of the control level. AmB-des (0.2 to 2 ,ug/ml) (but not AmB-LC [.40 jg/ml]) decreased chemotaxis of pure PMNs to fMLP by as much as 35% and that of PMNs in the presence of MNLs by as much as 50%. l)esoxycholate by itself had no effect on PMN function. These differences in activity between AmB-des and AmB-LC may explain the lessened toxicity observed with AmB-LC.
Amphotericin B (AmB) is a widely used antifungal agent. In several laboratories (3, 9, 18, 22, 33, 37) it has been observed that in vitro neutrophil (polymorphonuclear leukocyte [PMN] ) function is altered by AmB. Other laboratories have reported that AmB affects macrophage function (6, 17, 27, 36) and stimulates monokine production from both human and murine cells (8, 14) . Because both tumor necrosis factor-a (TNF-a) and interleukin-lp (IL-1p) have inflammatory actions on PMN function, we hypothesized that the increased expression of these monokines might exacerbate the effects of AmB on PMN function. We found that the presence of mononuclear leukocytes (MNLs) increases the effects of AmB on PMN function.
There are a number of side effects observed with AmB treatment, including fever, chills, thrombophlebitis, anemia, and nephrotoxicity (5, 21) . The inflammatory action of AmB on leukocyte function could contribute to the toxicity of AmB both by direct action on PMN function and by indirect mechanisms through the expression and release of endogenous mediators. A lipid-complexed preparation of AmB (AmB-LC), which is in phase II clinical trials, has been reported to be less toxic to mice (as measured by survival) in comparison with the toxicity of a desoxycholate-suspended preparation (AmB-des; Fungizone), while it retains its ef-(HSA) was from Cutter Biological (Elkhart, Ind.). Paraformaldehyde was from Eastman Organic Chemicals (Rochester, N.Y.). Anti-Leu-15 (anti-CD11b) and phycoerythrin-conjugated anti-Leu-M3 (anti-CD14) were from Becton Dickinson (Mountain View, Calif.), and fluorescein isothiocyanatelabeled goat anti-mouse IgG F(ab')2 fragments (heavy and light chain specific) were from Cappel (West Chester, Pa.).
Leukocyte preparation. Purified PMNs (-98% PMNs and >95% viable by trypan blue exclusion) containing less than one platelet per five PMNs and <50 pg of endotoxin (Limulus amebocyte lysate assay) per ml were obtained from normal heparinized (10 U/ml) venous blood by a one-step Ficoll-Hypaque separation procedure (13) . Residual Chemiluminescence is a measure of PMN oxidative activity. The light is emitted from unstable high-energy oxygen species generated by activated PMNs (7) . Purified PMNs (1 x 106/ml) or PMNs (1 x 106/ml) added to MNLs (2 x 106/ml) were incubated (37°C for 0 to 90 min) in 1 ml of either diluent (HBSS, 0.1% HSA), desoxycholate, AmB-des, AmB-LC, or undiluted MNL-conditioned medium. Luminol (1) (5 x 10' M) was then added, and the cells were transfered to a vial (37°C) with a stirring bar. Chemiluminescence was read with a Chronolog photometer (Havertown, Pa.) for 1 min in the absence of fMLP, and then fMLP (1 ,uM) was added and the chemiluminescence assay was continued for an additional 7 min. The relative fMLP-stimulated chemiluminescence in 7 min was determined by weighing the cut chart paper (the area under the curves, i.e., the paper weights [in milligrams] = relative light units). In some experiments PMNs or PMNs plus MNLs were stimulated with AmB-des or AmB-LC instead of fMLP.
Whole-blood PMN NBT test. The NBT test is another assay of the oxidative activity of neutrophils (2) . A wholeblood NBT test modified from the methods of Ochs and Igo (25) was used. Whole blood was drawn with no anticoagulant. AmB-des, desoxycholate, or AmB-LC was immediately added to some whole-blood samples, and diluent was added to control samples. Two drops of each sample were placed onto a clean coverslip and incubated for 25 min (37°C and 5% C02) in a moist chamber. The clot was then washed off with 37°C normal saline, and the coverslip was inverted onto 3 drops of a 1% NBT solution in HBSS-35% heat inactivated pooled human serum and incubated for 20 min at 37°C. The coverslip was then washed with normal saline, fixed in methanol, and counterstained with safranin stain. The samples were coded, and the NBT-positive PMNs (blue) were counted under a light microscope.
Mac-i expression by PMNs. PMN Mac-1 expression was analyzed by a modification of the method of Pichyangkul et al. (28) . PMNs (2 x 106/ml) or PMNs (1 x 106/ml) plus MNLs (1 x 106/ml) were suspended in 1 ml of RPMI 1640-10% heat-inactivated FBS (with or without AmB-des, AmB-LC, desoxycholate, or undiluted MNL-conditioned medium). The cells were incubated in 5-ml polystyrene tubes for 0 to 90 min at 37°C. The samples were then iced and washed two times with 1 ml of PBS (1.7 mM KH2PO4, 8 mM Na2HPO4, 117 mM NaCl, 0.5 mM CaCl2, 0.5 mM MgCl2)-5% heat-inactivated FBS. Anti-Leu-15 (0.1 ml of a 1/5 dilution in RPMI 1640-10% heat-inactivated FBS) (or control mouse IgG2a, kappa myeloma protein) was added to the cell button. The cells were incubated at 4°C for 30 min, fixed with 1 ml of 0.5% paraformaldehyde in PBS, and then washed two times with PBS-5% heat-inactivated FBS. The cell button was taken up in 0.1% secondary antibody [fuorescein isothiocyanate-labeled goat anti-mouse IgG F(ab')2 fragments; heavy and light chain specific and diluted 1/100 in PBS-5% heat-inactivated FBS], washed once with PBS-5% heat-inactivated FBS, and washed once with PBS containing 1% HSA. Each cell button was suspended in 1 ml of 0.5% paraformaldehyde in PBS and was stored for up to 3 days in the refrigerator. The fluorescence was read with a fluorescence-activated cell sorter (Epics 753; Epics Coulter). The cells were analyzed by light scatter to characterize the cells within the mixed leukocyte preparation into PMN and MNL subpopulations. The PMN population was analyzed by fluorescence for Mac-1 content. Fluorescence (as mean channel intensity) was converted from a 3-decade logarithmic scale to a linear scale (1 to 1,000), and then the relative linear fluorescence was compared with unstimulated activity by dividing by the fluorescence level of nonincubated baseline PMN fluorescence and multiplying by 100. There was little detectable fluorescence in those samples that were reacted with the control mouse myeloma protein rather than antiLeu-15 (less than 1% of baseline PMN fluorescence either in the presence or absence of AmB-des). For some samples, we selectively analyzed PMNs (CD14-cells) within the light scatter map by staining with (phycoerythrin-anti-Leu-M3, which stains for CD14+ cells (monocytes). We gated for the cells with low phycoerythrin fluorescence (PMNs) and observed that this did not alter the results either in the absence or presence of AmB-des.
PMN migration. Chemotaxis under agarose was quantitated by the method of Nelson et al. (24) . Purified PMNs (5 x 106) or PMNs (5 x 106) plus MNLs (3 x 106) were incubated in either diluent (HBSS, 0.1% HSA), desoxycholate, AmB-des, or AmB-LC. Nondirected and directed migration to fMLP (100 nM) was measured after 2 h of incubation at 37°C. Microscopic examination of the stained chemotaxis plates revealed that >99% of the cells in the PMN-MNL assays which had migrated out of the wells by 2 h were PMNs.
TNF-a and IL-1" assays. To determine whether soluble IL-lp and TNF-a were present in the mixed leukocyte cultures (PMNs and MNLs), we assayed samples for these cytokines. PMNs (5 x 106) were incubated with MNLs (3 x 106) with or without AmB-des, AmB-LC, and desoxycholate in 1 ml of HBSS-0.1% HSA for 90 min at 37°C. The samples were then iced and centrifuged at 2,000 x g for 5 min, and the cell-free supernatants were frozen (-70°C) for later enzyme-linked immunosorbent assay (ELISA) analysis. In a parallel set of samples, indomethacin (1 ,ug/ml) was added to maximize cytokine expression (14) .
TNF-a and IL-1i were assayed by ELISA with kits purchased from Endogen Inc. (Boston, Mass.) and Cistron Biotechnology (Pine Brook, N.J.). Statistical analysis. Significance (P < 0.050) was determined by two-tailed paired Student's t test.
RESULTS
PMN viability. The viability of PMNs incubated (37°C) for 90 min without AmB was 95 + 1%. Peak concentrations of AmB-des (2 ,ug/ml for 90 min) in serum did not significantly decrease PMN viability (94 + 2%; P = 0.232). Incubation with AmB-des (5 ,ug/ml for 90 min) slightly decreased PMN viability to 91 ± 2% (P = 0.022), and AmB-LC (20 ,ug/ml for 90 min) minimally decreased PMN viability to 92 ± 2% (P = 0.044).
AmB-LC is a less potent stimulator of PMN chemiluminescence (with or without MNLs) than is AmB-des. It was observed that AmB-des stimulated little PMN chemiluminescence in the absence of fMLP (data not shown), but priming of PMNs with AmB-des (1 to 5 ,ug/ml for 90 min) increased the oxidative burst (P < 0.050). AmB-des (1, 2, and 5 ,ug/ml) increased PMN chemiluminescence more than the same concentrations of AmB-LC (P < 0.025) did, while much higher concentrations of AmB-LC (20 ,ug/ml) only slightly increased PMN chemiluminescence (P = 0.046) (Fig.  1 ). MNLs (no PMNs) either in the presence or absence of AmB-des or AmB-LC displayed little chemiluminescence in response to fMLP (data not shown). PMNs-MNLs increased fMLP-stimulated PMN chemiluminescence in the absence of AmB (P = 0.001), and PMNs-MNLs plus AmB-des (2 ,ug/ml) (but not AmB-LC) minimally stimulated chemiluminescence in the absence of fMLP (31% of fMLP-stimulated PMNsMNLs). PMNs-MNLs plus AmB-LC (20 jig/ml) doubled fMLP-stimulated chemiluminescence (P = 0.040). PMNsMNLs plus AmB-des (1 and 2 jig/ml) markedly increased fMLP-stimulated chemiluminescence; the AmB-des-primed fMLP-stimulated activity was greater than that observed with the same concentrations of AmB-LC (P = 0.004 for both) (Fig. 1) . Priming of the oxidative burst by AmB-des (2 jig/ml) in PMN-MNL preparations was a time-dependent process. AmB-des (for 90-min but not shorter incubations) significantly increased the oxidative burst stimulated by fMLP (P = 0.003) compared with that stimulated by PMNs-MNLs incubated for 90 min without AmB-des (Fig. 2) .
Cell-free AmB-des-stimulated, MNL-conditioned medium was able to prime pure PMNs for increased chemiluminescence. The activity with AmB-des-stimulated MNL-conditioned medium was 37°C ) with or without AmB-des (2 ,ug/ml), AmB-LC (2 ,ug/ml), unstimulated MNL-conditioned medium, AmBdes (2 ,ug/ml)-stimulated MNL-conditioned medium, or AmB-LC (2 ,ug/ml)-stimulated MNL-conditioned medium. The results are expressed as means ± standard errors of the mean (n = 5 to 14 separate experiments). *, P = 0.001; fMLP-stimulated PMN chemiluminescence was increased by cell-free AmB-des-stimulated MNL-conditioned medium compared with that by unstimulated MNL-conditioned medium.
whole MNLs and was significantly greater than those with pure PMNs primed with AmB-des (2 jig/ml) (P = 0.003), cell-free unstimulated MNL-conditioned medium (P = 0.001), the sum of unstimulated MNL-conditioned medium and AmB-des (2 ,ug/ml) (P = 0.001), and AmB-LC-stimulated MNL-conditioned medium (P = 0.011). Thus, it appears that AmB-des stimulates the release of a mediator(s) from the MNLs, which augments PMN chemiluminescence (Fig. 3) .
AmB-des (2 ,jg/ml) contained 1.6 jxg of desoxycholate per ml. This concentration of desoxycholate did not stimulate PMN chemiluminescence, nor did it prime PMNs for increased oxidative activity in response to fMLP either in the absence or presence of MNLs (data not shown).
Thus, AmB-des primes PMNs for an increased oxidative response to fMLP, the priming effects of AmB-des and AmB-LC are greater in the presence of MNLs, cell-free AmB-des-stimulated MNL-conditioned medium primes pure PMNs for increased oxidative activity in response to fMLP, and AmB-des is a more potent primer of the PMN oxidative response than is AmB-LC.
AmB-des (but not AmB-LC) stimulates PMN oxidative activity in whole blood. As a second indicator of oxidative activity, we measured NBT reduction by PMNs in whole blood. AmB-des (2 pug/ml) increased the number of NBTpositive PMNs in whole blood from 31 to 52% (P = 0.04).
Neither desoxycholate (1.6 pugIml) nor AmB-LC (2 ,ug/ml) significantly altered PMN oxidative activity (Fig. 4) 4 . Effect of AmB-des and AmB-LC on PMN NBT reduction in whole blood. Whole blood was allowed to clot (30 min at 37°C) on glass coverslips with or without AmB-des (2 ,ug/ml), desoxycholate (DC; 1.6 ,ug/ml), or AmB-LC (2 ,ug/ml); and the adherent cells were assayed for NBT reduction. The results are expressed as percent NBT-positive PMNs and are means ± standard errors of the mean (n = 7 separate experiments). *, P = 0.041; AmB-des increased the number of NBT-positive PMNs. 0.008), and AmB-des further increased PMN Mac-1 expression in preparations containing MNLs (Fig. 5 and 6A and B) . In contrast, AmB-LC (2 to 40 ,ug/ml for 90 min) did not increase PMN Mac-1 expression in the presence of MNLs (Fig. 6A) . Desoxycholate (1.6 ,ug/ml) did not affect PMN Mac-1 expression either in the absence or presence of MNL (data not shown).
Cell-free unstimulated MNL-conditioned medium did not significantly affect PMN Mac-1 expression (108 ± 5% of expression on PMN incubated with diluent; P = 0.132). PMNs incubated with cell-free AmB-des (2 ,ug/ml)-stimulated MNL-conditioned medium expressed slightly more Mac-1 on their surfaces (125 + 5% of the expression on PMN in diluent; P = 0.025 compared with that of PMNs incubated with unstimulated MNL-conditioned medium).
AmB-des (but not AmB-LC) decreases PMN motility, especially in the presence of MNL. Diminished PMN motility is seen with inflammatory activators such as TNF-a (12, 26, 30) and IL-ip (31) . It has been observed previously (3, 18, 37) that AmB diminishes PMN motility. We exposed PMNs to AmB for 0 to 90 min prior to the chemotaxis assay and observed that AmB-des (2 j,g/ml) decreased PMN-directed migration (Fig. 7) . Although MNLs had little effect on PMN migration (2.48 + 0.14 mm with PMNs and 2.32 + 0.15 mm with PMNs-MNLs; P = 0.049), AmB inhibition was greater in the presence of MNLs (P < 0.050) (Fig. 7) MNLs being present (Fig. 8A and B) . In contrast to AmBdes, AmB-LC did not decrease PMN-directed migration to fMLP in the absence or presence of MNL (Fig. 8A and B) .
AmB-des decreased PMN-nondirected migration both in the presence and absence of MNL, but AmB-LC did not Effect of AmB-des on PMN-directed migration to fMLP (100 nM). PMNs (5 x 106/ml) or PMNs (5 x 106/ml) plus MNLs (3 x 106/ml) were preincubated (37°C) with or without AmB-des (2 ,ug/ml), and then PMN-directed migration to fMLP was assayed. The results are expressed as PMN leading front-directed migration to fMLP (100 nM) (in millimeters) and are means + standard errors of the mean (n = 5 separate experiments). *, P < 0.050; AmB-des decreased PMN migration more in the presence of MNLs than it did in the absence of MNLs. affect PMN-nondirected migration in the absence or presence of MNL ( Fig. 8A and B) .
Desoxychoiate (1.6 ,ug/ml) did not decrease PMN-directed or -nondirected migration either in the presence or absence of MNLs (data not shown).
Since endotoxin stimulates MNLs to release cytokines that can decrease PMN chemotaxis, we added polymyxin B (2 ,ug/ml) to some preparations to test for a possible effect of contaminating endotoxin in the AmB-des mixed leukocyte preparations. We observed that polymyxin B did not prevent AmB-des inhibition of PMN-directed migration to fMLP in the presence of MNLs (data not shown). Hence, it does not appear that contaminating endotoxin is involved in AmB inhibition of PMN migration in mixed leukocyte samples.
AmB-des (but not AmB-LC) stimulates IL-1B release from mixed leukocyte preparations. Analysis of supernatants from leukocyte preparations (5 x 106 PMNs per ml and 3 x 106 MNLs per ml) mixed for 90 min revealed that cell suspensions incubated with AmB-des (2 ,ug/ml) had 63 + 20 pg of IL-lp per ml compared with <5 pg/ml in the samples with desoxycholate (1.6 jig/ml) (P = 0.061) or AmB-LC (2 jig/ml) (P = 0.059), and all the samples had <12 pg of TNF-a-per ml. The addition of indomethacin (1 jig/ml) to the cultures increased the amount of IL-lp secreted in AmB-des-treated samples to 71 19 pg/ml. This was significantly greater than that observed with desoxycholate (1.6 ,ug/ml) plus indomethacin (<5 pg/ml) (P = 0.038) or AmB-LC plus indomethacin (<5 pg/mi) (P = 0.039). (19, 29) . Recently, it has been reported that neither AmB in dimethyl sulfoxide plus empty dipalmitoylphosphatidylcholine liposomes nor liposome-encapsulated AmB (containing <8 x 10-6 M AmB) lyses erythrocytes. In contrast, 50% hemolysis was observed with 5 x 10-6 M AmB in dimethyl sulfoxide (29) . Empty dipalmitoylphosphatidylcholine liposomes administered to mice 2 min before AmB was administered decreased AmB toxicity to mice (as measured by survival) (29 (32) and decreases PMN chemotaxis (31) . Thus, IL-13 could contribute to the action of AmB-des on PMN function. Factors other than IL-ip which could also contribute to this observed indirect effect of mixed mononuclear leukocytes on AmB-stimulated PMN function include other proinflammatory cytokines (e.g., gamma interferon and TNF-a), which either may be released into the medium or may be cell-associated, and the endogenous lipid mediators, platelet activating factor, leukotriene B4, and thromboxanes.
There is evidence that macrophage function is affected by AmB treatment. In vitro, AmB induces TNF-a production by murine macrophages (8) , potentiates macrophage activation by gamma interferon (36) , increases monocyte-derived human macrophage oxidative activity in response to phorbol myristate acetate (35) , and increases murine Mycobacterium bovis BCG-activated macrophage tumoricidal function (6) .
In vivo, treatment of mice with AmB results in macrophages which are primed for an increased oxidative response to zymosan and H. capsulatum. This response is synergistically amplified by the coadministration of gamma interferon (36) . In addition, Lin et al. (17) report that the macrophages from AmB-treated mice are more phagocytic and antimicrobial than control macrophages. In 
